Selected article for: "acute respiratory syndrome and admission mean age"
Author: Freites Nuñez, Dalifer D; Leon, Leticia; Mucientes, Arkaitz; Rodriguez-Rodriguez, Luis; Font Urgelles, Judit; Madrid García, Alfredo; Colomer, Jose I; Jover, Juan A; Fernandez-Gutierrez, Benjamín; Abasolo, Lydia
Title: Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases
  • Cord-id: cfci8lef
  • Document date: 2020_8_7
    • ID: cfci8lef
    Snippet: OBJECTIVES: To describe patients with autoimmune inflammatory rheumatic diseases (AIRD) who had COVID-19 disease; to compare patients who required hospital admission with those who did not and assess risk factors for hospital admission related to COVID-19. METHODS: An observational longitudinal study was conducted during the pandemic peak of severe acute respiratory syndrome coronavirus 2 (1 March 2020 to 24 April). All patients attended at the rheumatology outpatient clinic of a tertiary hospit
    Document: OBJECTIVES: To describe patients with autoimmune inflammatory rheumatic diseases (AIRD) who had COVID-19 disease; to compare patients who required hospital admission with those who did not and assess risk factors for hospital admission related to COVID-19. METHODS: An observational longitudinal study was conducted during the pandemic peak of severe acute respiratory syndrome coronavirus 2 (1 March 2020 to 24 April). All patients attended at the rheumatology outpatient clinic of a tertiary hospital in Madrid, Spain with a medical diagnosis of AIRD and with symptomatic COVID-19 were included. The main outcome was hospital admission related to COVID-19. The covariates were sociodemographic, clinical and treatments. We ran a multivariable logistic regression model to assess risk factors for the hospital admission. RESULTS: The study population included 123 patients with AIRD and COVID-19. Of these, 54 patients required hospital admission related to COVID-19. The mean age on admission was 69.7 (15.7) years, and the median time from onset of symptoms to hospital admission was 5 (3–10) days. The median length of stay was 9 (6–14) days. A total of 12 patients died (22%) during admission. Compared with outpatients, the factors independently associated with hospital admission were older age (OR: 1.08; p=0.00) and autoimmune systemic condition (vs chronic inflammatory arthritis) (OR: 3.55; p=0.01). No statistically significant findings for exposure to disease-modifying antirheumatic drugs were found in the final model. CONCLUSION: Our results suggest that age and having a systemic autoimmune condition increased the risk of hospital admission, whereas disease-modifying antirheumatic drugs were not associated with hospital admission.

    Search related documents:
    Co phrase search for related documents
    • acute phase and admission require: 1, 2
    • acute phase and admission treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute phase and liver disease: 1, 2, 3, 4, 5, 6
    • acute phase reactant and admission treatment: 1
    • acute phase reactant elevated and admission treatment: 1
    • acute respiratory insufficiency and admission pneumonia: 1